BusinessFinTechFunding

Tollys: Raises Over €1.5M from Bpifrance

Tollys: Raises Over €1.5M from Bpifrance

  • Funding consists of 50% non-dilutive funding and 50% long-term loans
  • The company will use the funding for the preclinical development of TL-532 in cancer immunotherapy
  • In May 2020, Tollys closed a round of financing totaling €2.3m ($2.5M)
  • Founded in 2015 by Philippe Guillot-Chêne, chief business officer, and Vincent Charlon, chief executive officer
  • Then the company is pioneering TL-532, a new cancer immunotherapy to treat various types of cancer
  • Tollys discovered and patented a family of TLR3 agonists and selected TL-532 as its lead-candidate
Previous article
Aldi Nord: Selected Fiserv to enable all in-store card payments
Next article
Mission Therapeutics: Raises $15M in Funding
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Spektr Strengthens Compliance Efforts with $20M Funding

Fintech startup Spektr secures $20 million for AI-driven compliance solutions.Highlights: Spektr raises $20 million to enhance its AI...
FinTech

Hacked DeFi Platform Drift Secures Funds to Repay Customers

Drift plans to relaunch with Tether support after addressing security issues.Highlights: Drift DeFi platform has secured funds after...
FinTech

Business Banking Fintech Slash Reaches Unicorn Status

The fintech startup achieves a valuation of over $1 billion.Highlights: Slash has been valued at over $1 billion.The...
FinTech

Amex Strengthens Digital Services with AI Expense Management Acquisition

American Express to acquire Hyper to enhance its business offerings.Highlights: American Express announces the acquisition of AI startup...